JUN |
JUN: Transcription factor AP-1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
31.240 |
Evidence |
O
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
31.240 |
Evidence |
O
|
CDK2 |
CDK2: Cell division protein kinase 2 |
CCNH |
CCNH: Cyclin-H |
31.240 |
Evidence |
O
|
CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
CREBBP |
CREBBP, CBP: CREB-binding protein |
31.240 |
Evidence |
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
ATF1 |
ATF1: Cyclic AMP-dependent transcription factor ATF-1 |
31.240 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
31.230 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
31.110 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
31.110 |
Evidence |
|
ARHGEF7 |
IPI00449908 |
GIT2 |
IPI00238218 |
31.110 |
Evidence |
|
RB1 |
RB1: Retinoblastoma-associated protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
31.040 |
Evidence |
O
|
RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
ARHGDIA |
ARHGDIA, GDIA1: Rho GDP-dissociation inhibitor 1 |
31.000 |
Evidence |
O
|
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
JAK1 |
|
30.910 |
Evidence |
|
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
30.910 |
Evidence |
|
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
30.910 |
Evidence |
O
|
PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
PSMD7 |
PSMD7, MOV34L: 26S proteasome non-ATPase regulatory subunit 7 |
30.480 |
Evidence |
O
|
PSMD7 |
PSMD7, MOV34L: 26S proteasome non-ATPase regulatory subunit 7 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
30.480 |
Evidence |
O
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
EP300 |
IPI00478752 |
30.290 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
30.160 |
Evidence |
|
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
30.160 |
Evidence |
|
CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
CXCR3 |
CXCR3, GPR9: C-X-C chemokine receptor type 3 |
30.090 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
30.080 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
30.080 |
Evidence |
O
|
PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
PSMD13 |
PSMD13: 26S proteasome non-ATPase regulatory subunit 13 |
30.070 |
Evidence |
O
|
PRKAB2 |
PRKAB2: 5'-AMP-activated protein kinase subunit beta-2 |
PRKAG1 |
PRKAG1: 5'-AMP-activated protein kinase subunit gamma-1 |
30.070 |
Evidence |
O
|
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
30.020 |
Evidence |
O
|